Stock listing
Frankfurt:RB0 Regenxbio Inc. Aktie
German listing (Frankfurt) of Regenxbio Inc. · home listing NASDAQ:RGNX
Follow Regenxbio Inc. into a list and get an email when it puts out news.
Share price · FWB:RB0
€6.57 EUR +0.72 (+12.3%)
Close on Oct 30, 2026
- Day range
- €6.57 – €6.57 EUROct 30, 2026
- Market cap
- €433.7M EURAt the close on Oct 30, 2026 · price × 66.01M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:RGNX · Home | $7.20 USD | -0.21 (-2.8%) | 1,061,611 | $7.38 | $7.535 | $7.00 | $7.41 | Close on Oct 30, 2026 |
| Frankfurt:RB0 | €6.57 EUR | +0.72 (+12.3%) | — | €6.57 | €6.57 | €6.57 | €5.85 | Close on Oct 30, 2026 |
- Ticker
- Frankfurt:RB0
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Oct 29, 2026
REGENXBIO to Host Conference Call on November 5 to Discuss Third Quarter 2026 Financial Results and Operational Highlights
Latest earnings call · Aug 6, 2026
REGENXBIO (NASDAQ:RGNX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 40 slides
Calls
Upcoming
REGENXBIO (NASDAQ:RGNX) Q3 2026 Earnings Call
Thu, Nov 05, 2026 · 8:00 AM ET
Register
Replays
REGENXBIO (NASDAQ:RGNX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptREGENXBIO (NASDAQ:RGNX) Q1 2026 Earnings Call
Thu, May 14, 2026 · 8:00 AM ET
Watch TranscriptREGENXBIO (NASDAQ:RGNX) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Financings
Public offering of common stock and pre-funded warrants
Aug 6, 2026
Closed: US$108M raised · US$9 a share · Morgan Stanley +3
Dealers: Morgan Stanley (co-lead), J.P. Morgan (co-lead), Leerink Partners (co-lead), Mizuho (co-lead)
Use of proceeds: Extend cash runway into Q4 2027 and support the planned AFFINITY RISE ex-U.S. randomized-controlled trial of RGX-202 in 1H 2027
Decks
Investor Presentation (September 2026)
Investor deck · 40 slides · September 2026
American Society of Retina Specialists (ASRS) 2026
Conference · 10 slides · July 2026
Q4 2025 Earnings Presentation
Earnings · 23 slides · Mar 5, 2026
AAO 2025
Conference · 23 slides · Oct 17, 2025
Regenxbio Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 221 in all · newest Oct 29, 2026 · oldest 2019
- Calls
- 24 calls with a replay · 24 with a transcript · latest Aug 6, 2026
- Decks
- 21 decks · latest September 2026
Where Regenxbio Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:RGNX · Home listing | NASDAQ | United States | USD |
| gettex:RB0 | gettex | Germany | EUR |
| LS Exchange:A140E0 | LS Exchange | Germany | EUR |
| Tradegate:RB0 | Tradegate | Germany | EUR |
| Lang & Schwarz:A140E0 | Lang & Schwarz | Germany | EUR |
| Frankfurt:RB0 · This page | Frankfurt | Germany | EUR |
| BOATS:RGNX | BOATS | United States | USD |
| Munich:RB0 | Munich | Germany | EUR |
| Dusseldorf:RB0 | Dusseldorf | Germany | EUR |
| Stuttgart:RB0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Regenxbio Inc.